Zymeworks (ZYME) Current Taxes (2022 - 2026)
Zymeworks recorded quarterly Current Taxes of $66000.0 in Q1 2026, down 20.48% quarter-over-quarter from $83000.0 in Q4 2025, and down 48.03% year-over-year from $127000.0 in Q1 2025.
Zymeworks' Current Taxes history runs 5 years deep, the most recent figure standing at $66000.0 for Q1 2026.
- In Q1 2026, Current Taxes fell 48.03% year-over-year to $66000.0; the TTM figure through Mar 2026 stood at $66000.0 (down 48.03% YoY), while the FY2025 annual figure was $83000.0, down 35.16% from the prior year.
- Current Taxes came in at $66000.0 for Q1 2026 at Zymeworks, down from $83000.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $2.1 million in Q3 2024 to a low of $66000.0 in Q1 2026.
- A 5-year average of $919142.9 and a median of $840000.0 in 2022 frame the typical range for Current Taxes.
- Across the five-year window, Current Taxes surged 149.22% in 2024 and plunged 94.73% in 2025, its largest moves.
- Zymeworks' Current Taxes stood at $840000.0 in 2022, then surged by 115.6% to $1.8 million in 2023, then sank by 92.93% to $128000.0 in 2024, then tumbled by 35.16% to $83000.0 in 2025, then declined by 20.48% to $66000.0 in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $66000.0, $83000.0, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 10,460.56 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 19.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | 66,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66,000.00 |
| Dec 31, 2025 | 83,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 102,000.00 |
| Mar 31, 2025 | 127,000.00 |
| Dec 31, 2024 | 128,000.00 |
| Sep 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 1.93 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 1.81 Mn |
| Sep 30, 2023 | 831,000.00 |
| Jun 30, 2023 | 1.16 Mn |
| Mar 31, 2023 | 840,000.00 |
| Dec 31, 2022 | 840,000.00 |